Institutional members access full text with Ovid®

Share this article on:

Patient Management Problem—Preferred Responses

Briemberg, Hannah R. MD, FRCPC

doi: 10.1212/CON.0000000000000410
Self-Assessment and CME

Address correspondence to Dr Hannah R. Briemberg, 2775 Laurel St, Vancouver, BC V5Z 1M9, Canada,

Relationship Disclosure: Dr Briemberg serves on the editorial board of Continuum and has received personal compensation for serving as a consultant for Novartis AG and also has received publishing royalties from BMJ Publishing Group Ltd and UpToDate, Inc. Dr Briemberg has received research support related to the Canadian Neuromuscular Disease National Registry from the University of Calgary and has received research/grant support as medical director of the amyotrophic lateral sclerosis clinic from the Amyotrophic Lateral Sclerosis Society of British Columbia.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Briemberg discusses the unlabeled/investigational use of immunosuppressive medications for the treatment of autoimmune myositis.

© 2016 American Academy of Neurology
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website